Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: Microarray-related NIH Grants: May 15, 2012

Premium

Microarray-Related NIH Grants, Jan. 1 – May 10, 2012

Development and Validation of a Panel of Antibodies for the Diagnosis of Sarcoidosis
Principal investigator: Lobelia Samavati
Organization: Wayne State University
Project start date: Jan. 1, 2012
Project end date: Dec. 31, 2013
NIH institute: NHLBI
FY 2012 funding amount: $182,200

BioArray News spoke with Samavati about the project in February (BAN 2/7/2012).


Using Signatures of T-helper Cell Inflammation to phenotype Human Asthma
Principal investigator: Nirav Bhakta
Organization: University of California, San Francisco
Project start date: Jan. 1, 2012
Project end date: Dec. 31, 2012
NIH institute: NHLBI
FY 2012 funding amount: $58,100


Genomic Profiling of Yeast Resistance to AFB1, a P450-activated Carcinogen
Principal investigator: Michael Fasullo
Organization: State University of New York at Albany
Project start date: Jan. 10, 2012
Project end date: Jan. 14, 2013
NIH institute: NIEHS
FY 2012 funding amount: $62,030


Novel Methods for the Inhibition of Phosphate Function
Principal investigator: Jeffrey Gustafson
Organization: Yale University
Project start date: Jan. 12, 2012
Project end date: Jan. 11, 2014
NIH institute: NIGMS
FY 2012 funding amount: $47,114


Negative Regulation of Virulence in Pseudomonas aeruginosa
Principal investigator: Albert Siryaporn
Organization: Princeton University
Project start date: Feb. 1, 2012
Project end date: Jan. 31 2015
NIH institute: NIAID
FY 2012 funding amount: $53,942


ATP as the Instigator of Inflammatory Responses to Spinal Cord Injury
Principal investigator: Maiken Nedergaard
Organization: University of Rochester
Project start date: Feb. 1, 2012
Project end date: Jan. 31, 2017
NIH institute: NINDS
FY 2012 funding amount: $337,969


Characterization of Bleach-specific Transcriptional Regulators in Bacteria
Principal investigator: Ursula Jakob
Organization: University of Michigan at Ann Arbor
Project start date: Feb. 1, 2012
Project end date: Jan. 31, 2014
NIH institute: NIAID
FY 2012 funding amount: $228,003


Identifying Borrelia turicatae Genes Needed for Colonization and Transmission From
Principal investigator: Job Lopez
Organization: Mississippi State University
Project start date: Feb. 15, 2012
Project end date: Jan. 31, 2014
NIH institute: NIAID
FY 2012 funding amount: $162,000


BCAR3 and Its Role in Breast Cancer Tumor Progression, Invasion, and Metastasis
Principal investigator: Ashley Wilson
Organization: University of Virginia at Charlottesville
Project start date: March 1, 2012
Project end date: Feb. 28, 2015
NIH institute: NCI
FY 2012 funding amount: $29,078


Innate Immune Response to Microbial Pamps in the Schistosome-transmitting Snail
Principal investigator: John Sullivan
Organization: University of San Francisco
Project start date: March 1, 2012
Project end date: Feb. 28, 2013
NIH institute: NIAID
FY 2012 funding amount: $296,713


Novel Approaches for Prevention and Treatment of Noise-induced Hearing Loss
Principal investigator: Debashree Mukherjea
Organization: Souther Illinois University School of Medicine
Project start date: March 1, 2012
Project end date: Feb. 28, 2015
NIH institute: NIDCD
FY 2012 funding amount: $145,500


Mechanistic Studies of EGFR/ERBB Receptor Tyrosine Kinases
Principal investigator: Daniel Leahy
Organization: Johns Hopkins University
Project start date: March 1, 2012
Project end date: Jan. 31, 2016
NIH institute: NIGMS
FY 2012 funding amount: $307,800


Reduced NADH Production in the Presence of Tryptophan as a Biomarker of Autism Spectrum Disorders
Principal investigator: Charles Schwartz
Organization: Greenwood Genetic Center
Project start date: March 9, 2012
Project end date: Feb. 28, 2013
NIH institute: NICHHD
FY 2012 funding amount: $148,327


The Impact of Uncertainty in Genome-wide Testing for Autism Spectrum Disorders
Principal investigator: Marian Reiff
Organization: University of Pennsylvania
Project start date: March 9, 2012
Project end date: Dec. 31, 2012
NIH institute: NHGRI
FY 2012 funding amount: $240,000

BioArray News spoke with Reiff about the project last month (BAN 2/7/2012).


Functional Evolution of Chromosomal Inversions in Anopheles arabiensis
Principal investigator: Jose Ranz
Organization: University of California, Irvine
Project start date: March 15, 2012
Project end date: March 14, 2014
NIH institute: NIAID
FY 2012 funding amount: $227,625


Multiplexed Bead-based In Vitro Pediatric Allergy Test
Principal investigator: Mark Lim
Organization: Ambergen
Project start date: March 15, 2012
Project end date: Feb. 28, 2014
NIH institute: NIAID
FY 2012 funding amount: $298,459


Defining the Role and Regulation of the Rho GEF Ect2 in Ovarian Cancer Cells
Principal investigator: Lauren Huff
Organization: University of North Carolina at Chapel Hill
Project start date: March 16, 2012
Project end date: March 15 2014
NIH institute: NCI
FY 2012 funding amount: $29,392


Roles of miR-17-92 Cluster microRNAs in KRAS-Induced Pancreatic Tumorigenesis
Principal investigator: Brian Quattrochi
Organization: University of Massachusetts Medical School in Worcester
Project start date: April 1, 2012
Project end date: March 31, 2016
NIH institute: NCI
FY 2012 funding amount: $28,746


Stem/Progenitor Cells of the Chondrocyte and Osteoblast Lineage In Vivo
Principal investigator: Noriaki Ono
Organization: Massachusetts General Hospital
Project start date: April 1, 2012
Project end date: March 31, 2014
NIH institute: NIDCR
FY 2012 funding amount: $137,970


Understanding the Early and Late Endosomal TLR9-mediated Responses to Viral DNA
Principal investigator: Yong-Jun Liu
Organization: Baylor Research Institute
Project start date: April 1, 2012
Project end date: March 31, 2017
NIH institute: NIAID
FY 2012 funding amount: $392,000


Developing Novel Serological Biomarkers for Autoimmune Liver Diseases
Principal investigator: Xuhang Li
Organization: Johns Hopkins University
Project start date: April 1, 2012
Project end date: March 31, 2014
NIH institute: NIAID
FY 2012 funding amount: $245,969


The Role of DNA Methylation in Tumor Maintenance
Principal investigator: Peter Laird
Organization: University of Southern California
Project start date: April 1, 2012
Project end date: March 31, 2017
NIH institute: NCI
FY 2012 funding amount: $339,781


Transcriptional Regulation by a Deacetylase, CBB, in a Periodontopathogen
Principal investigator: David Kolodrubetz
Organization: University of Texas Health Science Center in San Antonio
Project start date: April 1, 2012
Project end date: Feb. 28, 2014
NIH institute: NIDCR
FY 2012 funding amount: $223,626


Determinants of Individual Variability in AS Cytotoxicity
Principal investigator: Walter Klimecki
Organization: University of Arizona
Project start date: April 1, 2012
Project end date: March 31, 2015
NIH institute: NIEHS
FY 2012 funding amount: $178,075


Identifying Biomarkers and Genetic Risk Factors Predictive of Reproductive Sequelae
Principal investigator: Toni Darville
Organization: University of Pittsburgh
Project start date: April 1, 2012
Project end date: March 31, 2014
NIH institute: NIAID
FY 2012 funding amount: $167,201


Systems Biology Analysis of In Vivo Impact of Substance on HIV Infection
Principal investigator: Harris Goldstein
Organization: Albert Einstein College of Medical Yeshiva University
Project start date: April 1, 2012
Project end date: March 31, 2017
NIH institute: NIDA
FY 2012 funding amount: $575,758


High-throughput HLA-typing on Raw, Unpurified Cord Blood Samples
Principal investigator: Michael Hogan
Organization: Genomics USA (now GMS Biotech)
Project start date: April 15, 2012
Project end date: March 31, 2014
NIH institute: NHLBI
FY 2012 funding amount: $105,000

BioArray News spoke with Hogan about the project earlier this month (BAN 5/1/2012).


Studies of Lymphoma Suppression and DNA Repair
Principal investigator: Chunying Du
Organization: University of Cincinnati
Project start date: May 1, 2012
Project end date: March 31, 2013
NIH institute: NCI
FY 2012 funding amount: $325,775

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.